CD133, OCT4, and NANOG in ulcerative colitis-associated colorectal cancer

By Yasuda Hiromi   Tanaka Koji   Okita Yoshiki   Araki Toshimitsu   Saigusa Susumu   Toiyama Yuji   Yokoe Takeshi   Yoshiyama Shigeyuki   Kawamoto Aya   Inoue Yasuhiro   Miki Chikao   Kusunoki Masato  

Oncology Letters, Vol. 2, Iss. 6, 2011-11 ,pp. : 1065-1071

Spandidos Publications

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor-γ is downregulated in ulcerative colitis and is involved in experimental colitis-associated neoplasia

By        

Oncology Letters, Vol. 10, Iss. 3, 2015-01 ,pp. : 1259-1266

Spandidos Publications

Access to resources Recommend Favorite

The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells

By                                        

International Journal of Oncology, Vol. 46, Iss. 4, 2015-01 ,pp. : 1551-1559

Spandidos Publications

Access to resources Recommend Favorite

Parthenolide induces apoptosis in colitis-associated colon cancer, inhibiting NF-κB signaling

By                  

Oncology Letters, Vol. 9, Iss. 5, 2015-01 ,pp. : 2135-2142

Spandidos Publications

Access to resources Recommend Favorite

Soluble interleukin-6 receptor to interleukin-6 (sIL6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy

By                    

Oncology Letters, Vol. 2, Iss. 5, 2011-01 ,pp. : 861-864

Spandidos Publications

Access to resources Recommend Favorite